|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
03347 TIGERMED
Nominal 
32.350 -1.650 (-4.853%) Profitability Analysis
| 2023/12 | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| ROAA (%) | 7.095% | 7.877% | 13.315% | 12.937% | 13.842% |
| ROAE (%) | 9.959% | 10.663% | 16.769% | 17.169% | 23.781% |
| Return on Capital Employed (%) | 7.934% | 8.501% | 13.499% | 9.535% | 14.615% |
Margin Analysis
| 2023/12 | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| Gross Profit Margin (%) | 38.199% | 39.312% | 43.121% | 47.093% | 46.085% |
| EBITDA Margin (%) | 35.389% | 38.032% | 69.776% | 72.384% | 43.454% |
| Pre-tax Profit Margin (%) | 33.724% | 36.623% | 70.768% | 69.551% | 38.839% |
| Net Profit Margin (%) | 27.444% | 28.454% | 55.224% | 54.861% | 30.009% |
Liquidity Analysis
| 2023/12 | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| Current Ratio (X) | 2.740 X | 2.978 X | 4.497 X | 10.220 X | 1.858 X |
| Quick Ratio (X) | 2.735 X | 2.972 X | 4.494 X | 10.216 X | 1.857 X |
Leverage Analysis
| 2023/12 | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| Total Liabilities / Total Assets(%) | 17.611% | 17.363% | 13.209% | 8.447% | 27.044% |
| Total Debt / Total Assets (%) | 11.275% | 9.909% | 4.101% | 1.699% | 14.319% |
| Net Debt / Total Assets (%) | -13.656% | -18.447% | -31.189% | -49.362% | -12.200% |
| Total Debt / Shareholders' Funds (%) | 15.884% | 13.855% | 5.354% | 2.051% | 25.516% |
| Long Term Debt / Shareholders' Funds (%) | 4.069% | 3.738% | 2.237% | 1.727% | 3.971% |
| Net Debt / Shareholders' Funds (%) | -19.238% | -25.795% | -40.718% | -59.606% | -21.741% |
| Net Cash / (Debt) ($) | 4.053B | 5.063B | 7.405B | 9.629B | 923.293M |
| Net Cash / (Debt) per share ($) | 4.646 | 5.804 | 8.487 | 11.036 | -- |
| Total Debt / Capital Employed (%) | 13.102% | 11.467% | 4.565% | 1.804% | 18.826% |
| Interest Coverage Ratio (X) | 21.769 X | 32.197 X | 149.113 X | 44.726 X | 26.774 X |
Efficiency Analysis
| 2023/12 | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| Inventory Turnover (Day) | 1.824 Day | 1.201 Day | 0.666 Day | 0.640 Day | 0.208 Day |
| Receivables Turnover (Day) | 56.715 Day | 47.647 Day | 45.917 Day | 51.677 Day | 46.959 Day |
| Payables Turnover (Day) | 10.066 Day | 7.877 Day | 8.722 Day | 10.090 Day | 7.761 Day |
| Remarks: | Real time quote last updated: 22/11/2024 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB 492,849 |
| %Change | -64.501% |
| EPS / (LPS) | RMB 0.570 |
| NBV Per Share (¥) | RMB 24.007 |